mRNA Vaccines
Vaccines that deliver messenger RNA instructions for cells to produce antigens and stimulate targeted immune protection.
Core metadata
- ID: mrna_vaccines
- Era: Modern
- First known date: 2020 (exact)
- Region: United States, Germany, and global vaccine programs
- Review status: source_checked
- Maturity: established
Prerequisites
- Lipid Nanoparticles (lipid_nanoparticles)
- Molecular Biology (molecular_biology)
- Modern Vaccine Development (vaccine_development_modern)
Dependents
Fields
Field lanes
- Pharmaceuticals & Drug Development: Biologics & Vaccines
Node sources
- Vaccine Types (U.S. Department of Health and Human Services, 2026, official_agency) • Supports: node, maturity
- Vaccines (U.S. Food and Drug Administration, 2026, official_agency) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 74%
- Prerequisite sources: 3
- expert_inference: 2
- review: 1
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Molecular Biology (molecular_biology) | enabling | 68% | expert_inference | Molecular Biology provides a capability that enables this technology without being the only possible path. |
|
| Modern Vaccine Development (vaccine_development_modern) | enabling | 68% | expert_inference | Modern Vaccine Development provides a capability that enables this technology without being the only possible path. |
|
| Lipid Nanoparticles (lipid_nanoparticles) | enabling | 86% | review | Lipid nanoparticles are a central delivery method for approved mRNA vaccines, though not the only conceivable RNA-delivery route. |
|
This page is generated from canonical era JSON and is indexable by URL.